Bee Saliva, Bee Spit, Gelée Royale, Honey Bee Milk, Honey Bee's Milk, Jalea Real, Lait des Abeilles, Royal Bee Jelly.<br/><br/>


Overview Information

Royal jelly is a milky secretion produced by worker honey bees. It typically contains about 60% to 70% water, 12% to 15% proteins, 10% to 16% sugar, 3% to 6% fats, and 2% to 3% vitamins, salts, and amino acids. Its composition varies depending on geography and climate. This product gets its name from the fact that bees use it for the development and nurturing of queen bees. Some people use royal jelly as medicine. Don’t confuse royal jelly with bee pollen or bee venom.

Royal jelly is used for asthma, hay fever, liver disease, pancreatitis, type 2 diabetes, diabetic foot ulcers, sleep troubles (insomnia), fatigue (tiredness) secondary to cancer, premenstrual syndrome (PMS), infertility (inability to have a child), menopausal symptoms, stomach ulcers, kidney disease, bone fractures, menopausal symptoms, skin disorders, and high cholesterol. It is also used as a general health tonic, for fighting the effects of aging, and for boosting the immune system.

Some people apply royal jelly directly to the skin as a tonic or to the scalp to encourage hair growth.

How does it work?

There is very little scientific information available about the effects of royal jelly in people. In animals, royal jelly seems to have some activity against tumors and the development of “hardening of the arteries.”


Uses & Effectiveness?

Possibly Effective for

  • Menopausal symptoms. Early research shows that taking royal jelly by mouth for 3 months can increase high-density lipoprotein (HDL or “good”) cholesterol and decrease low-density lipoprotein (LDL or “bad”) cholesterol in postmenopausal women. Other research shows that taking a product containing royal jelly and flower pollen by mouth for 12 weeks can reduce menopausal symptoms and improve feelings of well-being in menopausal women. Another product containing royal jelly, evening primrose oil, damiana, and ginseng also seems to decrease menopausal symptoms. Applying royal jelly in the vagina may improve quality of life and sexual problems in menopausal women similarly to intravaginal estrogen. But applying estrogen inside the vagina seems to reduce vaginal inflammation in menopausal women better than royal jelly.

Possibly Ineffective for

  • Seasonal allergies (hayfever). Taking a specific royal jelly product (Bidro) by mouth for 3-6 months before and during pollen season does not seem to improve stuffy nose, sneezing, or eye discomfort in children with seasonal allergies.

Insufficient Evidence for

  • Tiredness in people with cancer. Early research shows that taking a mixture of processed honey and royal jelly twice daily for 4 weeks improves feelings of tiredness in some people with cancer.
  • Diabetes. Some research shows that taking royal jelly by mouth once daily for 8 weeks improves average blood sugar and blood insulin levels in people with diabetes. But other research shows that taking royal jelly as a single dose or three times daily for 8 weeks doesn’t improve blood sugar or blood insulin levels in people with diabetes.
  • Diabetic foot ulcers. Some early research shows that applying royal jelly to ulcers after cleansing and removal of dead tissue does not improve healing. But other early research shows that applying a specific ointment containing royal jelly and panthenol for up to 6 months after cleansing and removal of dead tissue may improve the healing of diabetic foot ulcers.
  • Infertility. Early research shows that applying a solution containing royal jelly, Egyptian bee honey, and bee bread to the vagina for 2 weeks may increase the rate of pregnancy in couples with fertility problems due to reduced sperm movement (asthenozoospermia).
  • High cholesterol. Early research shows that taking royal jelly by mouth might lower cholesterol levels in people with high cholesterol.
  • Premenstrual syndrome (PMS). Early research shows that taking a product containing royal jelly, bee pollen extract, and bee pollen with pistil extract by mouth for 2 menstrual cycles decreases some symptoms of PMS including irritability, weight increases, and swelling.
  • Weight loss. Research shows that taking royal jelly by mouth once daily for 8 weeks slightly decreases body weight in overweight people with diabetes. But the improvement might not be clinically meaningful.
  • Asthma.
  • Baldness.
  • Bone fractures.
  • Boosting immunity.
  • Kidney disease.
  • Liver disease.
  • Pancreatitis.
  • Skin disorders.
  • Stomach ulcers.
  • Trouble sleeping (insomnia).
  • Other conditions.
More evidence is needed to rate the effectiveness of royal jelly for these uses.
Side Effects

Side Effects & Safety

Royal jelly is POSSIBLY SAFE for most people when taken by mouth appropriately. A specific product containing a combination of royal jelly, bee pollen extract, and bee pollen plus pistol extract (Femal by Natumin Pharma) has been used safely for up to 2 months. Another combination product containing royal jelly and flower pollen (Melbrosia) has been used safely for up to 3 months. Royal jelly might cause serious allergic reactions including asthma, swelling of the throat, and death. Rarely, it might cause the colon to bleed, accompanied by stomach pain and bloody diarrhea.

Royal jelly is also POSSIBLY SAFE when applied to the skin appropriately. However, it has caused inflammation and allergic rash when applied to the scalp.

Special Precautions & Warnings:

Children: Royal jelly is POSSIBLY SAFE when taken by mouth for up to 6 months.

Pregnancy and breast-feeding: There is not enough reliable information about the safety of using royal jelly if you are pregnant or breast-feeding. Stay on the safe side and avoid use.

Asthma or allergies: Don’t use royal jelly if you have asthma or allergies to bee products. It could cause some serious reactions, even death.

Inflamed skin (dermatitis): Royal jelly might make dermatitis worse.

Low blood pressure: Royal jelly might lower blood pressure. If your blood pressure is already low, taking royal jelly might make it drop too much.



Moderate Interaction

Be cautious with this combination

  • Warfarin (Coumadin) interacts with ROYAL JELLY

    Royal jelly might increase the effects of warfarin (Coumadin). Taking royal jelly with warfarin (Coumadin) might result in an increased chance of bruising or bleeding.



The following doses have been studied in scientific research:


  • Menopausal symptoms: 150 mg of royal jelly has been taken daily for 3 months. One or two capsules of a product containing royal jelly and flower pollen has been used for up to 12 weeks. Two capsules of a product containing royal jelly, evening primrose oil, damiana, and ginseng has been taken daily for 4 weeks.

View References


  • Sitar, J. and Cernochova, Z. [Treatment of stenocardia with Vita-Apinol SPOFA. On some metabolic effects of the drug]. Vnitr.Lek. 1968;14(8):798-805. View abstract.
  • Sultana, A., Nabi, A. H., Nasir, U. M., Maruyama, H., Suzuki, K. M., Mishima, S., and Suzuki, F. A dipeptide YY derived from royal jelly proteins inhibits renin activity. Int.J.Mol.Med. 2008;21(6):677-681. View abstract.
  • Szanto, E., Gruber, D., Sator, M., Knogler, W., and Huber, J. C. [Placebo-controlled study of melbrosia in treatment of climacteric symptoms]. Wien.Med.Wochenschr. 1994;144(7):130-133. View abstract.
  • Takahama, H. and Shimazu, T. Food-induced anaphylaxis caused by ingestion of royal jelly. J.Dermatol. 2006;33(6):424-426. View abstract.
  • Taniguchi et al. Oral administration of Royal Jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. Int Immunopharmacol. 2003;3(9):1313-1324.
  • Testi, S., Cecchi, L., Severino, M., Manfredi, M., Ermini, G., Macchia, D., Capretti, S., and Campi, P. Severe anaphylaxis to royal jelly attributed to cefonicid. J.Investig.Allergol.Clin.Immunol. 2007;17(4):281. View abstract.
  • Thien, F. C., Leung, R., Plomley, R., Weiner, J., and Czarny, D. Royal jelly-induced asthma. Med.J.Aust. 11-1-1993;159(9):639. View abstract.
  • Tokunaga, K. H., Yoshida, C., Suzuki, K. M., Maruyama, H., Futamura, Y., Araki, Y., and Mishima, S. Antihypertensive effect of peptides from royal jelly in spontaneously hypertensive rats. Biol.Pharm.Bull. 2004;27(2):189-192. View abstract.
  • Vinogradova, T. V. and Zajcev G. P. Pcela i zdorovie celoveka (Bee and the health of man). Roselschozizdat Moskva 1964;1.
  • Vittek, J. and Kresanek J. A contribution to chemical investigation of royal jelly and possibilities of applying it in therapy. Acta pharm.Pharmac., Bohemoslov. 1965;10:83-125.
  • Abdelhafiz, A. T. and Muhamad, J. A. Midcycle pericoital intravaginal bee honey and royal jelly for male factor infertility. Int J Gynaecol Obstet 2008;101(2):146-149. View abstract.
  • Albert S, Bhattacharya D, Klaudiny J, et al. The family of major royal jelly proteins and its evolution. J Mol Evol 1999;49:290-297. View abstract.
  • Bullock RJ, et al. Fatal royal jelly-induced asthma. Med J Aust 1994;160:44.
  • Bullock RJ, Rohan A, Straatmans JA. Fatal royal jelly-induced asthma. Med J Aust 1994;160:44. View abstract.
  • Georgiev DB, Metka M, Huber JC, et al. Effects of an herbal medication containing bee products on menopausal symptoms and cardiovascular risk markers: results of a pilot open-uncontrolled trial. MedGenMed 2004;6:46. View abstract.
  • Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. N Z Med J 1996;109:325.
  • Lambrinoudaki I, Augoulea A, Rizos D, Politi M, Tsoltos N, Moros M, Chinou I, Graikou K, Kouskouni E, Kambani S, Panoulis K, Moutsatsou P. Greek-origin royal jelly improves the lipid profile of postmenopausal women. Gynecol Endocrinol. 2016 May 26:1-5. View abstract.
  • Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440.
  • Lee NJ, Fermo JD. Warfarin and royal jelly interaction. Pharmacotherapy 2006;26:583-6. View abstract.
  • Leung R, Ho A, Chan J, et al. Royal jelly consumption and hypersensitivity in the community. Clin Exp Allergy 1997;27:333-6. View abstract.
  • Leung R, Thien FC, Baldo B, et al. Royal jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. J Allergy Clin Immunol 1995;96:1004-7.
  • Lombardi C, Senna GE, Gatti B, et al. Allergic reactions to honey and royal jelly and their relationship with sensitization to compositae. Allergol Immunopathol (Madr) 1998;26:288-90. View abstract.
  • Mofid B, Rezaeizadeh H, Termos A, Rakhsha A, Mafi AR, Taheripanah T, Ardakani MM, Taghavi SM, Moravveji SA, Kashi AS. Effect of Processed Honey and Royal Jelly on Cancer-Related Fatigue: A Double-Blind Randomized Clinical Trial. Electron Physician. 2016 Jun 25;8(6):2475-82. View abstract.
  • Peacock S, Murray V, Turton C. Respiratory distress and royal jelly. BMJ 1995;311:1472.
  • Pourmoradian S, Mahdavi R, Mobasseri M, Faramarzi E, Mobasseri M. Effects of royal jelly supplementation on body weight and dietary intake in type 2 diabetic females. Health Promot Perspect. 2012 Dec 28;2(2):231-5. View abstract.
  • Pourmoradian S, Mahdavi R, Mobasseri M, Faramarzi E, Mobasseri M. Effects of royal jelly supplementation on glycemic control and oxidative stress factors in type 2 diabetic female: a randomized clinical trial. Chin J Integr Med. 2014 May;20(5):347-52. View abstract.
  • Roger A, Rubira N, Nogueiras C, et al. [Anaphylaxis caused by royal jelly]. Allergol Immunopathol (Madr) 1995;23:133-5. View abstract.
  • Seyyedi F, Rafiean-Kopaei M, Miraj S. Comparison of the Effects of Vaginal Royal Jelly and Vaginal Estrogen on Quality of Life, Sexual and Urinary Function in Postmenopausal Women. J Clin Diagn Res. 2016 May;10(5):QC01-5. View abstract.
  • Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements: a 5-year toxicological study (1991-1995). Drug Saf 1997;17:342-56. View abstract.
  • Shidfar F, Jazayeri S, Mousavi SN, Malek M, Hosseini AF, Khoshpey B.Does Supplementation with Royal Jelly Improve Oxidative Stress and Insulin Resistance in Type 2 Diabetic Patients? Iran J Public Health. 2015 Jun;44(6):797-803. View abstract.
  • Siavash M, Shokri S, Haghighi S, Shahtalebi MA, Farajzadehgan Z. The efficacy of topical royal jelly on healing of diabetic foot ulcers: a double-blind placebo-controlled clinical trial. Int Wound J. 2015 Apr;12(2):137-42. View abstract.
  • Takahashi M, Matsuo I, Ohkido M. Contact dermatitis due to honeybee royal jelly. Contact Dermatitis 1983;9:452-5. View abstract.
  • Takahashi M, Matsuo I, Ohkido M. Contact dermatitis due to honeybee royal jelly. Contact Dermatitis 1983;9:452-5. View abstract.
  • Thien FC, Leung R, Baldo BA, et al. Asthma and anaphylaxis induced by royal jelly. Clin Exp Allergy 1996;26:216-22. View abstract.
  • Vittek J. Effect of royal jelly on serum lipids in experimental animals and humans with atherosclerosis. Experientia 1995;51:927-35. View abstract.
  • Winther K, Hedman C. Assessment of the Effects of the Herbal Remedy Femal on the Symptoms of Premenstrual Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study. Curr Ther Res Clin Exp 2002;63:344-53..
  • Yakoot M, Salem A, and Omar AM. Effectiveness of a herbal formula in women with menopausal syndrome. Forsch Komplementmed 2011;18(5):264-268. View abstract.
  • Yonei Y, Shibagaki K, Tsukada N, et al. Case report: haemorrhagic colitis associated with royal jelly intake. J Gastroenterol Hepatol 1997;12:495-9. View abstract.
  • Yuksel S, Akyol S. The consumption of propolis and royal jelly in preventing upper respiratory tract infections and as dietary supplementation in children. J Intercult Ethnopharmacol. 2016 Mar 31;5(3):308-11. View abstract.
  • Blomhoff, R. [Antioxidants and oxidative stress]. Tidsskr.Nor Laegeforen. 6-17-2004;124(12):1643-1645. View abstract.
  • Bodiroga, T., Bodiroga, M., and Ognjanovic, J. Etheric oils in aromatherapia in Yugoslavia. Int Pharm Fed World Cong 2002;62:135.
  • Boelens, M. H. and Boelens, H. Chemical and sensory evaluation of three sage oils. Perfumer & Flavorist 1997;22:19-40.
  • Bol'shakova, I. V., Lozovskaia, E. L., and Sapezhinskii, I. I. [Antioxidant properties of plant extracts]. Biofizika 1998;43(2):186-188. View abstract.
  • Boszormenyi, A., Hethelyi, E., Farkas, A., Horvath, G., Papp, N., Lemberkovics, E., and Szoke, E. Chemical and genetic relationships among sage ( Salvia officinalis L.) cultivars and Judean sage ( Salvia judaica Boiss.). J Agric.Food Chem. 6-10-2009;57(11):4663-4667. View abstract.
  • Bouaziz, M., Yangui, T., Sayadi, S., and Dhouib, A. Disinfectant properties of essential oils from Salvia officinalis L. cultivated in Tunisia. Food Chem.Toxicol. 2009;47(11):2755-2760. View abstract.
  • Bozin, B., Mimica-Dukic, N., Samojlik, I., and Jovin, E. Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J Agric.Food Chem. 9-19-2007;55(19):7879-7885. View abstract.
  • Brieskorn, C. H. and Biechele, W. [Flavones from Salvia officinalis L. 22. Components of Salvia off. L]. Arch Pharm Ber.Dtsch Pharm Ges. 1971;304(8):557-561. View abstract.
  • Brieskorn, C. H. and Biechele, W. Differentiation of Salvia officinalis and Salvia triloba. Deutshe Apotheker-Zeitung 1971;111:141-142.
  • Brieskorn, C. H. and EBERHARDT, K. H. [Oxytriterpenic acids of sage oil. 9. Constituents of Salvia officinalis L..]. Arch.Pharm.Ber.Dtsch.Pharm.Ges. 1953;286(3):124-129. View abstract.
  • Brieskorn, C. H. and Glasz, J. [Salvia glycoprotein, a water soluble protein material from the seeds of Salvia officinalis L. 19. On the contents of Salvia officinalis L.]. Pharmazie 1965;20(6):382-384. View abstract.
  • Brieskorn, C. H. and Kapadia, Z. Bestandteile von Salvia officinalis XXIV: Triterpenalkohole, Triterpensauren und Pristan im Blatt von Salvia officinalis L. Planta Med 1980;38:86-90.
  • Brieskorn, C. H. and Kapadia, Z. Constituents of Salvia officinalis XXIII: 5-methoxysalvigenin in leaves of Salvia officinalis. Planta Med 1979;35:376-378.
  • Brieskorn, C. H. Salbei - seine Inhaltsstoffe und sein therapeutischer Wert. Z Phytotherapie 1991;(12):-61.
  • Burgar, M. I., Karba, D., and Kikelj, D. 13 C NMR analysis of essential oil of Dalmatian sage (Salvia officinalis). Farm Vestn 1979;30:253-261.
  • Capek, P. and Hribalova, V. Water-soluble polysaccharides from Salvia officinalis L. possessing immunomodulatory activity. Phytochemistry 2004;65(13):1983-1992. View abstract.
  • Capek, P., Hribalova, V., Svandova, E., Ebringerova, A., Sasinkova, V., and Masarova, J. Characterization of immunomodulatory polysaccharides from Salvia officinalis L. Int J Biol.Macromol. 2003;33(1-3):113-119. View abstract.
  • Capek, P., Machova, E., and Turjan, J. Scavenging and antioxidant activities of immunomodulating polysaccharides isolated from Salvia officinalis L. Int J Biol.Macromol. 1-1-2009;44(1):75-80. View abstract.
  • Carrasco, F. R., Schmidt, G., Romero, A. L., Sartoretto, J. L., Caparroz-Assef, S. M., Bersani-Amado, C. A., and Cuman, R. K. Immunomodulatory activity of Zingiber officinale Roscoe, Salvia officinalis L. and Syzygium aromaticum L. essential oils: evidence for humor- and cell-mediated responses. J Pharm.Pharmacol. 2009;61(7):961-967. View abstract.
  • Celik, I. and Isik, I. Determination of chemopreventive role of Foeniculum vulgare and Salvia officinalis infusion on trichloroacetic acid-induced increased serum marker enzymes lipid peroxidation and antioxidative defense systems in rats. Nat.Prod.Res 1-10-2008;22(1):66-75. View abstract.
  • Croteau, R. and Purkett, P. T. Geranyl pyrophosphate synthase: characterization of the enzyme and evidence that this chain-length specific prenyltransferase is associated with monoterpene biosynthesis in sage (Salvia officinalis). Arch.Biochem.Biophys. 1989;271(2):524-535. View abstract.
  • Croteau, R. and Satterwhite, D. M. Biosynthesis of monoterpenes. Stereochemical implications of acyclic and monocyclic olefin formation by (+)- and (-)-pinene cyclases from sage. J Biol.Chem. 9-15-1989;264(26):15309-15315. View abstract.
  • Croteau, R. B., Shaskus, J. J., Renstrom, B., Felton, N. M., Cane, D. E., Saito, A., and Chang, C. Mechanism of the pyrophosphate migration in the enzymatic cyclization of geranyl and linalyl pyrophosphates to (+)- and (-)-bornyl pyrophosphates. Biochemistry 12-3-1985;24(25):7077-7085. View abstract.
  • Croteau, R. B., Wheeler, C. J., Cane, D. E., Ebert, R., and Ha, H. J. Isotopically sensitive branching in the formation of cyclic monoterpenes: proof that (-)-alpha-pinene and (-)-beta-pinene are synthesized by the same monoterpene cyclase via deprotonation of a common intermediate. Biochemistry 8-25-1987;26(17):5383-5389. View abstract.
  • Croteau, R., El Bialy, H., and Dehal, S. S. Metabolism of Monoterpenes : Metabolic Fate of (+)-Camphor in Sage (Salvia officinalis). Plant Physiol 1987;84(3):643-648. View abstract.
  • Croteau, R., El-Bialy, H., and El-Hindawi, S. Metabolism of monoterpenes: lactonization of (+)-camphor and conversion of the corresponding hydroxyl acid to the glucoside-glucose ester in sage (Salvia officinalis). Arch Biochem Biophys 1984;228:667-680.
  • Croteau, R., Felton, M., Karp, F., and Kjonaas, R. Relationship of Camphor Biosynthesis to Leaf Development in Sage (Salvia officinalis). Plant Physiol 1981;67(4):820-824. View abstract.
  • Croteau, R., Satterwhite, D. M., Cane, D. E., and Chang, C. C. Biosynthesis of monoterpenes. Enantioselectivity in the enzymatic cyclization of (+)- and (-)-linalyl pyrophosphate to (+)- and (-)-pinene and (+)- and (-)-camphene. J Biol.Chem. 7-25-1988;263(21):10063-10071. View abstract.
  • Croteau, R., Satterwhite, D. M., Wheeler, C. J., and Felton, N. M. Biosynthesis of monoterpenes. Stereochemistry of the enzymatic cyclizations of geranyl pyrophosphate to (+)-alpha-pinene and (-)-beta-pinene. J Biol.Chem. 2-5-1989;264(4):2075-2080. View abstract.
  • Cwikla, C., Schmidt, K., Matthias, A., Bone, K. M., Lehmann, R., and Tiralongo, E. Investigations into the antibacterial activities of phytotherapeutics against Helicobacter pylori and Campylobacter jejuni. Phytother.Res 2010;24(5):649-656. View abstract.
  • Czarnecki, M., Dedio, I., Krysiuk, W., and Zalecki, R. Effect of the cultivation methods on crops and on the essential oil content in Herba salviae officinalis L. one year crop. Herba Polonica 1992;38:29-36.
  • da Rocha, M. D., Viegas, F. P., Campos, H. C., Nicastro, P. C., Fossaluzza, P. C., Fraga, C. A., Barreiro, E. J., and Viegas, C., Jr. The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II: Alzheimer's disease. CNS.Neurol.Disord.Drug Targets. 2011;10(2):251-270. View abstract.
  • Daniela, T. [Salvia officinalis l. I. Botanic characteristics, composition, use and cultivation]. Cesk.Farm. 1993;42(3):111-116. View abstract.
  • De, Leo, V, Lanzetta, D., Cazzavacca, R., and Morgante, G. [Treatment of neurovegetative menopausal symptoms with a phytotherapeutic agent]. Minerva Ginecol. 1998;50(5):207-211. View abstract.
  • Dehal, S. S. and Croteau, R. Metabolism of monoterpenes: specificity of the dehydrogenases responsible for the biosynthesis of camphor, 3-thujone, and 3-isothujone. Arch.Biochem.Biophys. 1987;258(1):287-291. View abstract.
  • Dehal, S. S. and Croteau, R. Partial purification and characterization of two sesquiterpene cyclases from sage (Salvia officinalis) which catalyze the respective conversion of farnesyl pyrophosphate to humulene and caryophyllene. Arch.Biochem.Biophys. 1988;261(2):346-356. View abstract.
  • Demo, A., Petrakis, C., Kefalas, P., and Boskou, D. Nutrient antioxidants in some herbs and Mediterranean plant leaves. Food Res Int 1998;31(5):351-354.
  • Dos Santos-Neto, L. L., Vilhena Toledo, M. A., Medeiros-Souza, P., and de Souza, G. A. The use of herbal medicine in Alzheimer's disease-a systematic review. Evid.Based.Complement Alternat.Med 2006;3(4):441-445. View abstract.
  • Dragland, S., Senoo, H., Wake, K., Holte, K., and Blomhoff, R. Several culinary and medicinal herbs are important sources of dietary antioxidants. J Nutr 2003;133(5):1286-1290. View abstract.
  • Dudai, N., Lewinsohn, E., Larkov, O., Katzir, I., Ravid, U., Chaimovitsh, D., Sa'adi, D., and Putievsky, E. Dynamics of yield components and essential oil production in a commercial hybrid sage (Salvia officinalis x Salvia fruticosa cv. Newe Ya'ar no. 4). J.Agric.Food Chem. 1999;47(10):4341-4345. View abstract.
  • Abd-Alhafiz AT, Abd-Almonem J. A simple treatment for asthenozoospermia-related subfertility: midcyclic pericoital vaginal micronized progesterone, bee honey and royal jelly. XVIII FIGO World Congress of Gynecology and Obstetrics. 2006;4(82)
  • Abdelatif, M., Yakoot, M., and Etmaan, M. Safety and efficacy of a new honey ointment on diabetic foot ulcers: a prospective pilot study. J.Wound.Care 2008;17(3):108-110. View abstract.
  • Andersen, A. H., Mortensen, S., Agertoft, L., and Pedersen, S. [Double-blind randomized trial of the effect of Bidro on hay fever in children]. Ugeskr.Laeger 9-19-2005;167(38):3591-3594. View abstract.
  • Baldo, B. A. Allergies to wheat, yeast and royal jelly: a connection between ingestion and inhalation? Monogr Allergy 1996;32:84-91. View abstract.
  • Boukraa, Laïd. Additive Activity of Royal Jelly and Honey Against Pseudomonas aeruginosa. Alternative Medicine Review. 2008;13(4):330-333.
  • Calli C, Tugyan K Oncel S Pýnar E Demirtaþoglu F Calli A Yucel B Yýlmaz O Kiray A. Effectiveness of Royal Jelly on Tympanic Membrane Perforations: An Experimental Study. Journal of Otolaryngology -- Head & Neck Surgery. 2008;37(2):179-184.
  • Chun SY, Feng TY Fu SY Kwong CC Jing GC. Royal jelly inhibited N-acetylation and metabolism of 2-aminofluorene in human liver tumor cells (J5). Toxicological & Environmental Chemistry. 2005;87:83-90.
  • Chupin SP, Sivokhov VL Bulnaeva GI. Use of Apilak (royal jelly) in sports medicine. Sports Training, Medicine & Rehabilitation. 1988;1(1):13-15.
  • El-Fiky S, Othman E Balabel E Abd-Elbaset S. The Protective Role of Royal Jelly Against Mutagenic Effect of driamycin and Gamma Radiation Separately and in Combination. Trends in Applied Sciences Research. 2008;3(4):303-318.
  • Erem, C., Deger, O., Ovali, E., and Barlak, Y. The effects of royal jelly on autoimmunity in Graves' disease. Endocrine. 2006;30(2):175-183. View abstract.
  • Fontana, R., Mendes, M. A., de Souza, B. M., Konno, K., Cesar, L. M., Malaspina, O., and Palma, M. S. Jelleines: a family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera). Peptides 2004;25(6):919-928. View abstract.
  • Gasic S, Vucevic D Vasilijic S Antunovic M Chinou I Colic M. Evaluation of the Immunomodulatory Activities of Royal Jelly Components In Vitro. Immunopharmacology & Immunotoxicology. 2007;3-4:521-536.

Vitamins Survey

Have you ever purchased ROYAL JELLY?

Did you or will you purchase this product in-store or online?

Where did you or where do you plan to purchase this product?

Where did you or where do you plan to purchase this product?

What factors influenced or will influence your purchase? (check all that apply)

Vitamins Survey

Where did you or where do you plan to purchase this product?

Do you buy vitamins online or instore?

What factors are most important to you? (check all that apply)

More Resources for ROYAL JELLY

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2018.